Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05396638 · ClinicalTrials.gov registry record · NA

Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder

A NA study of Cannabis Use, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05396638 is a NA study of Cannabis Use that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 30 participants, below the 279-participant average among 44 other Cannabis Use trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05396638, a NA study of Cannabis Use, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This project seeks to learn more about the effects of cannabis use on the endocannabinoid system and endogenous opioid systems in adolescents to address a fundamental gap in knowledge and identify biomarkers that may help distinguish youth who relapse from youth who remain sober.

Conditions Studied

Interventions

  • BEHAVIORAL Contingency Management

Study Locations (1)

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-10-13
Est. Completion 2025-12
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT05396638

The ClinicalTrials.gov registry entry for NCT05396638 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 279-participant average among 44 other Cannabis Use trials with a reported enrollment target (89% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cannabis Use appearing as the primary indexed condition, and to 1 intervention - of which Contingency Management is the first listed.

NCT05396638 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT05396638 about?

NCT05396638 is a clinical study titled "Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder". This project seeks to learn more about the effects of cannabis use on the endocannabinoid system and endogenous opioid systems in adolescents to address a fundamental gap in knowledge and identify biomarkers that may help distinguish youth who relapse from youth who remain sober.

What is the current status of trial NCT05396638?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-10-13. Estimated completion is 2025-12.

What conditions does trial NCT05396638 study?

This clinical trial studies the following conditions: Cannabis Use.

What interventions are being tested in trial NCT05396638?

The interventions under investigation include: Contingency Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT05396638?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05396638 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cannabis Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.